- Home
- CCRN vs ATXS Comparison
CCRN vs ATXS Comparison
Compare CCRN & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRN
- ATXS
- Stock Information
- Founded
- CCRN 1986
- ATXS 2008
- Country
- CCRN United States
- ATXS United States
- Employees
- CCRN N/A
- ATXS N/A
- Industry
- CCRN Professional Services
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- CCRN Consumer Discretionary
- ATXS Health Care
- Exchange
- CCRN Nasdaq
- ATXS Nasdaq
- Market Cap
- CCRN 468.2M
- ATXS 401.2M
- IPO Year
- CCRN N/A
- ATXS 2015
- Fundamental
- Price
- CCRN $14.26
- ATXS $4.04
- Analyst Decision
- CCRN Buy
- ATXS Strong Buy
- Analyst Count
- CCRN 4
- ATXS 5
- Target Price
- CCRN $18.41
- ATXS $26.60
- AVG Volume (30 Days)
- CCRN 322.4K
- ATXS 369.7K
- Earning Date
- CCRN 04-30-2025
- ATXS 05-08-2025
- Dividend Yield
- CCRN N/A
- ATXS N/A
- EPS Growth
- CCRN N/A
- ATXS N/A
- EPS
- CCRN N/A
- ATXS N/A
- Revenue
- CCRN $1,344,004,000.00
- ATXS N/A
- Revenue This Year
- CCRN N/A
- ATXS N/A
- Revenue Next Year
- CCRN $4.96
- ATXS N/A
- P/E Ratio
- CCRN N/A
- ATXS N/A
- Revenue Growth
- CCRN N/A
- ATXS N/A
- 52 Week Low
- CCRN $9.58
- ATXS $3.56
- 52 Week High
- CCRN $18.50
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- CCRN 29.19
- ATXS 28.96
- Support Level
- CCRN $14.00
- ATXS $3.56
- Resistance Level
- CCRN $15.01
- ATXS $4.39
- Average True Range (ATR)
- CCRN 0.38
- ATXS 0.42
- MACD
- CCRN 0.05
- ATXS -0.04
- Stochastic Oscillator
- CCRN 20.00
- ATXS 22.61
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.